Literature DB >> 2468788

Characterization of antibodies to synthetic nerve growth factor (NGF) and proNGF peptides.

T Ebendal1, H Persson, D Larhammar, K Lundströmer, L Olson.   

Abstract

Sequence data for the mature nerve growth factor (NGF) protein and its precursor are available from molecular cloning of the NGF gene in several species, including mice, humans, rats, and chickens. Hydrophilicity analysis of the predicted rat and chicken prepro-NGF was carried out to locate putative antigenic determinants. Eight peptides were selected and synthesized based on hydrophilicity profiles. Two peptides represent sequences in the rat (and mouse) pro-NGF, one peptide (our peptide P3) represents a highly conserved region of the mature NGF protein (identical in humans, mice, rats, and chickens), two peptides are specific for the mature chicken NGF, and the remaining three peptides are specific for the mature rat NGF (each with only one amino acid substitution compared with corresponding segments of the mouse NGF). For immunization, the peptides were conjugated to keyhold limpet hemocyanin and used to produce antisera in rabbits. After bleeding, peptide-specific antibodies were purified on affinity columns prepared by coupling each of the synthetic peptides. The different peptide antisera and affinity-purified antibodies then were characterized by enzyme-linked immunoassay (ELISA) and immunohistochemistry of the male mouse submandibular gland, a rich exocrine source of NGF. ELISA analysis showed that all peptide antisera bound two to four orders of magnitude better than normal rabbit serum to a coat of their proper peptide. The higher binding was retained by the purified peptide antibodies compared with normal rabbit immunoglobulin. Specific tests, in which one peptide antiserum was checked against different peptide coats in the ELISA, also showed two to four orders of magnitude higher binding of antibodies to the proper synthetic peptide. The peptide antibodies also were tested for their ability to bind to native mouse beta NGF coated to the immunoplates. Only antibodies raised to the conserved P3 peptide recognized native NGF to an extent similar to that obtained with polyclonal anti-NGF antibodies. Conversely, P3 was well recognized by several different NGF antisera. Immunohistochemically, both peptide antisera against the pro-NGF stained the perinuclear cytoplasm in the basal part of the cells of the granulated convoluted tubules in the mouse submandibular gland.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468788     DOI: 10.1002/jnr.490220302

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Large scale purification and immunological characterization of human placental nerve growth factor.

Authors:  E Bigon; C Soranzo; C Minozzi; S D Skaper; L Callegaro
Journal:  Neurochem Res       Date:  1990-12       Impact factor: 3.996

2.  Testicular atrophy and loss of nerve growth factor-immunoreactive germ cell line in rats exposed to n-hexane and a protective effect of simultaneous exposure to toluene or xylene.

Authors:  P Nylén; T Ebendal; M Eriksdotter-Nilsson; T Hansson; A Henschen; A C Johnson; T Kronevi; U Kvist; N O Sjöstrand; G Höglund
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  Detection of nerve growth factor and its mRNA by separate and combined immunohistochemistry and in situ hybridization in mouse salivary glands.

Authors:  C Ayer-Le Lievre; T Ebendal; L Olson; A Seiger; H Persson
Journal:  Histochem J       Date:  1989-01

4.  Two conserved domains in the NGF propeptide are necessary and sufficient for the biosynthesis of correctly processed and biologically active NGF.

Authors:  U Suter; J V Heymach; E M Shooter
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

5.  Structure-function studies of nerve growth factor: functional importance of highly conserved amino acid residues.

Authors:  C F Ibáñez; F Hallböök; T Ebendal; H Persson
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.